CD8A and glioma: CD8+ T-cells were shown to be essential for protection from tumor challenge in an experimental glioma model vaccinated with DC vaccine.44 A high CD8+ T-cell tumor infiltration as observed for Rutherrin-PDT is a possibility of prolonging survival.